Medovate partners with Eastern AHSN to support development of NHS-created medical device innovations

Medovate has today announced a new 5-year collaboration agreement with Eastern AHSN (Academic Health Science Network) to support their work of developing promising new medical device innovations arising from within the NHS.

Eastern AHSN were established by the NHS to help develop and deliver innovative solutions in health and care. Their purpose is to turn great ideas into positive health impact. As part of a national network, they do this by bringing together all partners in the health sector, to develop and deliver innovative care.

Medovate is a dedicated commercialisation vehicle for the NHS, working closely with clinical innovators to develop new medical technologies.

Working alongside the Eastern Academic Health Science Network will give the company the platform to engage key academic, health and clinical stakeholders in the region to help develop and adopt new medical device innovations.

Through this partnership Medovate plans to work with Eastern AHSN to support development of their medtech portfolio and share experiences with other innovators. This will include working with Clinical Key Opinion Leaders, developing clinical studies and economic business cases, as well as engagement with early NHS adoption centres.

Stuart Thomson, Managing Director at Medovate, commented: “We are delighted to be starting this new collaboration with Eastern AHSN. For Medovate, it will allow us gain early access to EAHSN’s expertise and support to help ensure innovations we work on are able to deliver impact and improved patient care.”

Louise Jopling, Commercial Director, Eastern Academic Health Science Network, added: “This is an exciting collaboration, and we are delighted to be working with Medovate in this capacity. The company have extensive experience in successfully bringing to global markets pioneering medical devices that can positively impact healthcare and the economy.”